Raihan Rabbani
-
- Antibiotic Use and Resistance 5
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 5
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 6
- Viral Infections and Vectors 6
-
- Nosocomial Infections in ICU 5
-
- Mosquito-borne diseases and control 6
-
- Long-Term Effects of COVID-19 5
- Co-authors
- Shihan Mahmud Redwanul HuqSitesh Chandra BacharArio SantiniYatin MehtaSubhash Prasad AcharyaZahirul IslamChandra Datta SumiRajib Paul
- Journals
- The Lancet (1 paper)SHILAP Revista de lepidopterología (6 papers)Cardiovascular Research (1 paper)
- Partner nations
- BangladeshUnited StatesAustralia
In The Last Decade
Raihan Rabbani
38 papers receiving 299 citations
Peers
Comparison fields: 5 of 84
- Applied Microbiology and Biotechnology 16
- Molecular Medicine 37
- Infectious Diseases 85
- Critical Care and Intensive Care Medicine 19
- Endocrinology 12
Countries citing papers authored by Raihan Rabbani
This map shows the geographic impact of Raihan Rabbani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raihan Rabbani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raihan Rabbani more than expected).
Fields of papers citing papers by Raihan Rabbani
This network shows the impact of papers produced by Raihan Rabbani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raihan Rabbani. The network helps show where Raihan Rabbani may publish in the future.
Co-authorship network
The 23 scholars most cited alongside Raihan Rabbani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 36 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 12 | |
| 8 | 2020 | 2 | |
| 9 | 2020 | 21 | |
| 10 | High Dose Tigecycline-Induced Mitochondrial Dysfunction-Associated Acute Metabolic Acidosis: A Retrospective Study | 2019 | 2 |
| 11 | 2019 | 9 | |
| 12 | 2019 | 21 | |
| 13 | 2018 | 3 | |
| 14 | 2017 | 12 | |
| 15 | 2015 | 0 | |
| 16 | 2015 | 1 | |
| 17 | 2013 | 2 | |
| 18 | 2012 | 0 | |
| 19 | Evaluation of Osteoporosis in a Selected Group of Iranian Patients with Ulcerative Colitis | 2009 | 2 |
| 20 | 1999 | 98 |
About Raihan Rabbani
Raihan Rabbani is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 46 papers that have together received 316 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (6 papers), Viral Infections and Vectors (6 papers), Mosquito-borne diseases and control (6 papers), Antibiotic Use and Resistance (5 papers), Antibiotic Resistance in Bacteria (5 papers), Nosocomial Infections in ICU (5 papers) and Long-Term Effects of COVID-19 (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (16 citations), Molecular Medicine (37 citations) and Infectious Diseases (85 citations). Raihan Rabbani has collaborated with scholars based in Bangladesh, United States and Australia. Frequent co-authors include Shihan Mahmud Redwanul Huq, Sitesh Chandra Bachar, Ario Santini, Yatin Mehta, Subhash Prasad Acharya, Zahirul Islam, Chandra Datta Sumi, Rajib Paul, Jahangir Alam and Seyed Mohammad Tavangar. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.